Skip to content

Clinical trials

Recruiting Phase 4 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 4 Status: Recruiting Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20191
20221
20231
20241
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alpha Cognition, Inc1
Eidos Therapeutics, a BridgeBio company1
First Affiliated Hospital of Wenzhou Medical University1
GlaxoSmithKline1
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1
Mayo Clinic1
NYU Langone Health1
The Fourth Affiliated Hospital of Zhejiang University School of Medicine1
University Hospital, Montpellier1
University of Texas at Austin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease10
Amyloid Neuropathies, Familial1
Amyloidosis1
Cardiomyopathies1
Cognitive Dysfunction1
Herpes Zoster1
Major Depressive Disorder1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.